Nippon India Pharma Fund - Growth Plan - Growth Option

NORMAL RISK
Equity
Equity: Sectoral-Pharma
6M returns
-2.11 %
Current NAV
496.60
1M3M6M1Y3Y5YALL
Loading...
Min. SIP
5000
AUM
₹ 8081.0 Cr

Return Calculator

Amount per month5,000
Over the past
1Y
3Y
5Y
Return amount NA
Total Investment
60,000

Investment distribution

Sun Pharmaceutical Industries13.4 %
Divi's Laboratories9.3 %
Lupin7.3 %
Cipla5.7 %
Apollo Hospitals Enterprise5.3 %
Dr. Reddy's Laboratories5.2 %

Fund Manager

SR
Sailesh Raj Bhan
AS
Akshay Sharma

Fund Information

Launched
18 Jul 2010(14 years ago)
Expense ratio1.82%
Exit LoadExit load of 1% if redeemed within 1 month.
Benchmark index
BSE Healthcare TRI100%

Fund Objective

The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.

Copyright ⓒ 2024 Cherry. All rights reserved.
appstoreplaystore